Dry Eye Syndrome Treatment Market Analysis, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Dry Eye Syndrome Treatment Market covers analysis by : Drugs (Lubricant Eye Drops, Anti-inflammatory Drugs, Autologous Serum Eye Drops) ; Products (Liquid Drops, Gel, Liquid Wipes, Eye Ointment) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Feb 2026
  • Report Code : TIPRE00005796
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Apr 2025

The Dry Eye Syndrome Treatment Market size is expected to reach US$ 10.58 Billion by 2031. The market is anticipated to register a CAGR of 6.9% during 2025-2031.

The research report is segmented by drugs into Lubricant Eye Drops, Anti-inflammatory Drugs, Autologous Serum Eye Drops. Products analyzed include Liquid Drops, Gel, Liquid Wipes, Eye Ointment. The global analysis is broken down by region and key countries, covering North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses.

Purpose of the Report

The report Dry Eye Syndrome Treatment Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Dry Eye Syndrome Treatment Market Segmentation Drugs

  1. Lubricant Eye Drops
  2. Anti-inflammatory Drugs
  3. Autologous Serum Eye Drops

Products

  1. Liquid Drops
  2. Gel
  3. Liquid Wipes
  4. Eye Ointment
Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Dry Eye Syndrome Treatment Market: Strategic Insights

dry-eye-syndrome-treatment-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Dry Eye Syndrome Treatment Market Growth Drivers

  1. Increasing Use of Digital Screens and Blue Light Exposure: One of the major factors driving this market is extended screen exposure. With digitalization at workplaces on the rise, along with smartphone, tablet, and computer use, people are exposed to digital screens for longer periods. Almost 60% of office workers in most parts of the world complain of digital eye strain in various studies, which always precedes DES. The blue light emitted from these devices further accentuates symptoms by destabilizing the tear film and increasing oxidative stress on the ocular surface. Recent developments have introduced eye lubricants specifically for digital users, aiming to remedy tear film instability. Besides this, awareness of screen breaks and protection with blue light-blocking eyewear is gaining momentum. With the rising trend of working from home, this demand for DES treatments will increase further, thus offering significant growth opportunities to the manufacturers of pharmaceuticals and eye care products.
  2. Aging Population and Rise in Prevalence of Age-Related Ocular Disorders: A very critical driver in the dry eye syndrome treatment market is the rise in the aging population globally. According to the United Nations, by 2050, the number of people aged 65 and over will increase twofold, reaching 1.5 billion. With aging, there is a natural reduction in tear production, thus predisposing the elderly to symptoms of dry eye. Furthermore, with age-related disorders, such as dysfunction of the meibomian glands, which affect the composition of tears, the symptoms of DES worsen. According to the National Eye Institute, about 75% of people over age 60 have some symptoms of dry eye. As such, pharmaceutical companies are also meeting this shifting demographic with new prescription eye drops and other minimally invasive procedures that address DES symptoms. The geriatric population is more likely to present for regular consultations in eye care, thereby increasing the demand for diagnosis and therapeutic solutions. This, therefore, creates a very good avenue of growth for the manufacturers dealing with geriatric-friendly treatments.
  3. Increased Prevalence of Autoimmune and Horminal Disorders: Growing prevalence of autoimmune diseases and hormonal disorders is a key factor that drives the demand in the dry eye syndrome treatment market. Other conditions such as SjReport Scope

    Dry Eye Syndrome Treatment Market Regional Insights

    The regional trends and factors influencing the Dry Eye Syndrome Treatment Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Dry Eye Syndrome Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

    Dry Eye Syndrome Treatment Market Report Scope

    By Products
    • Liquid Drops
    • Gel
    • Liquid Wipes
    • Eye Ointment
    Europe
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
    South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America
    Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
    Report Attribute Details
    Market size in 2024 US$ XX Billion
    Market Size by 2031 US$ 10.58 Billion
    Global CAGR (2025 - 2031) 6.9%
    Historical Data 2021-2023
    Forecast period 2025-2031
    Segments Covered By Drugs
    • Lubricant Eye Drops
    • Anti-inflammatory Drugs
    • Autologous Serum Eye Drops
    Regions and Countries Covered North America
    • US
    • Canada
    • Mexico
    Market leaders and key company profiles
    • Allergan plc
    • Otsuka Pharmaceutical Co., Ltd
    • Santen Pharmaceutical Co., Ltd
    • Nicox S.A
    • Auven Therapeutics Holdings L.P
    • Akorn, Incorporated
    • Bausch & Lomb Pvt Ltd
    • IMO
    • GlaxoSmithKline plc
    • Novartis AG

    Dry Eye Syndrome Treatment Market Players Density: Understanding Its Impact on Business Dynamics

    The Dry Eye Syndrome Treatment Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    dry-eye-syndrome-treatment-market-cagr
    • Get the Dry Eye Syndrome Treatment Market top key players overview

Frequently Asked Questions

1

What is the expected CAGR of the Dry Eye Syndrome Treatment Market?

The Dry Eye Syndrome Treatment Market is expected to register a CAGR of 6.9% from 2025-2031.
2

What are the driving factors impacting the Dry Eye Syndrome Treatment Market?

The major driving factors supporting the Dry Eye Syndrome Treatment Market growth are- Rising screen time and blue light exposure, growing aging population and age-related ocular disorders, increased prevalence of autoimmune and hormonal disorders.
3

What are the future trends in the Dry Eye Syndrome Treatment Market?

Key Future Trends in the Dry Eye Syndrome Treatment Market are- Technological advancements in DES treatment devices, the shift to biologic and personalized treatments, adoption of artificial intelligence (AI) in diagnosis and management.
4

Which are the key players in the Dry Eye Syndrome Treatment Market?

Key companies in the Dry Eye Syndrome Treatment Market are - Allergan plc, Otsuka Pharmaceutical Co., Ltd, Santen Pharmaceutical Co., Ltd, Nicox S.A, Auven Therapeutics Holdings L.P, Akorn, Incorporated, Bausch & Lomb Pvt Ltd, IMO, GlaxoSmithKline plc, Novartis AG
5

What are the deliverable formats of the Dry Eye Syndrome Treatment Market?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
6

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 35 company profiles and country-specific analysis of 35 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA